Document 0772
 DOCN  M9620772
 TI    Rational drug design and HIV: hopes and limitations.
 DT    9602
 AU    Goody RS; Max-Planck-Institut fur Molekulare Physiologie, Dortmund,;
       Germany.
 SO    Nat Med. 1995 Jun;1(6):519-20. Unique Identifier : AIDSLINE MED/96071493
 DE    *Antiviral Agents/CHEMISTRY/PHARMACOLOGY/THERAPEUTIC USE  Binding
       Sites/DRUG EFFECTS  *Drug Design  Drug Resistance, Microbial  Enzyme
       Inhibitors/CHEMISTRY/PHARMACOLOGY/THERAPEUTIC USE  Human  HIV
       Infections/*DRUG THERAPY  HIV Protease
       Inhibitors/CHEMISTRY/PHARMACOLOGY/THERAPEUTIC USE  Models, Molecular
       Molecular Structure  RNA-Directed DNA Polymerase/DRUG EFFECTS
       Structure-Activity Relationship  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).